YP Lu, HW Wu, T Zhu, XT Li, J Zuo,
AA Hasan… - Biomedicine & …, 2022 - Elsevier
Background Sodium glucose cotransporter 2 (SGLT2) inhibitors originally developed for the
treatment of type 2 diabetes are clinically very effective drugs halting chronic kidney disease …